CE vs NRIX · rev $10.28B vs rev $54.5M
Celanese Corporation (CE) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
CE currently screens at market cap $5.92B. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the CE and NRIX stock pages for the full models.
Not investment advice.